US37733W2044
US37733W2044
GSK PLC
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.7T EUR | 3.67T EUR | 4.18T EUR | 3.47T EUR |
Enterprise Value | 1.72T EUR | 3.69T EUR | 4.2T EUR | 3.48T EUR |
Valuation Multiples | ||||
Trailing P/E | 14.86x | 762.17x | 717.29x | 847.22x |
Forward P/E | -- | -- | -- | -- |
Price to Sales | 51.23x | 110.67x | 127.55x | 137.84x |
Price to Book | 4.11x | 208.24x | 234.21x | 211.69x |
EV/Revenue | 51.67x | 111.12x | 128.03x | 138.42x |
EV/EBITDA | 158.6x | 365.85x | 400.1x | 451.25x |
Price to FCF (P/FCF) | 488.42x | 689.26x | 878.93x | 854.11x |
EV/FCF | 492.64x | 692.09x | 882.21x | 857.7x |
FCF Yield | 0.2% | 0.15% | 0.11% | 0.12% |